NeoGenomics

+$0.27 (+0.62%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments.

CEO
Mark Mallon
Employees
1,700
Headquarters
Fort Myers, Florida
Founded
1998

NEO Key Statistics

Market Cap
5.36B
Price-Earnings Ratio
77.77
Dividend Yield
—
Average Volume
1.39M
High Today
$44.09
Low Today
$42.60
Open Price
$43.01
Volume
610.70K
52 Week High
$61.57
52 Week Low
$36.00

NEO Earnings

-$0.10
-$0.02
$0.06
$0.14
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure